Injective

Injective

Private
New York City, New YorkCrypto & Web3https://www.injective.com

Last Round

VC Round

Aug 10, 2022

Est. Valuation

$1B

Total Funding Raised

$2.6M

Momentum Score

50 /100

Company Overview

Injective is a blockchain technology company that offers a decentralized derivatives exchange protocol aimed at fostering a free and inclusive financial system through innovative solutions that enhance security and scalability in decentralized trading.

Sector

Crypto & Web3

Verticals

Blockchain Infrastructure, DeFi, Cross-Chain, Smart Contracts

Business Model

B2B2C

Customer Profile

Marketplace Commission, Revenue Share, Usage-Based SaaS

AI Layer

Non-AI

Keywords

on-chain order bookLayer-1 blockchainDeFi L1interoperable blockchainDeFi infrastructureCosmos SDKfinancial primitivesDeFi orderbookCosmos ecosystemplug-and-play modulescross-chain bridgesappchaintoken burnMEV-resistantCosmWasm smart contractsaltcoin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Injective Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Injective Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 10, 2022
Token SaleApr 20, 2021
SeedJul 28, 2020

Key People

Founding team and executive leadership

Albert Chon

Co-founder, CTO

Founding Team

Injective Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Integrated with Stargate Finance for advanced multichain capabilities.

  • Apr 15, 2026

    Partnered with NTT Digital for Japan market expansion.

Injective Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Injective Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Injective's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range122
Year Founded2018
Last FundingAug 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.